London Daily

Focus on the big picture.
Monday, Oct 20, 2025

US move on vaccine intellectual property is a 'monumental moment' in COVID-19 fight

US move on vaccine intellectual property is a 'monumental moment' in COVID-19 fight

A waiver could boost production by lifting intellectual property protections and the EU is also now willing to discuss the move.

The head of the World Health Organization says the US backing of a proposed waiver of intellectual property rights for COVID vaccines is a "monumental moment" in the fight against the virus.

A waiver - which Europe's leaders say they are now also ready to discuss - could significantly boost vaccine production around the world by lifting patents, copyrights and protections for industrial design and confidential information.

This could mean easier access to vaccines for those in poorer and middle-income countries, many of whom have been at the back of the queue while others such as the US and UK have been able to vaccinate large numbers of their own people.


But there were warnings from the pharmaceutical industry about potential harm to future innovation as well as the safety of vaccines being produced in a potential free-for-all.

Sceptics also pointed to other issues such as the apparent unwillingness of some countries to export vaccines, and production supply, rather than patents, being to blame for shortages.

The issue of global access to vaccines has become more urgent with the surge of cases in India, the world's second-most populous country.

WHO's director-general, Tedros Adhanom Ghebreyesus, has repeatedly urged the world to support the waiver proposal, which was initially brought to the World Trade Organisation (WTO) by India and South Africa in October last year.

After the announcement by the Biden administration, he said on Twitter: "This is a monumental moment in the fight against COVID-19.

"The commitment by (Joe Biden and US trade representative Katherine Tai) to support the waiver of IP protections on vaccines is a powerful example of United States leadership to address global health challenges."


More than 100 countries support the proposal and Mr Biden had been under growing pressure from a group within Congress - all fellow Democrats who backed the waiver.

European Commission president Ursula van der Leyen said the EU was "ready to discuss any proposals that address the crisis in an effective and pragmatic manner".

"That's why we are ready to discuss how the US proposal for a waiver on intellectual property protections for COVID-19 vaccines could help achieve that objective," she said.

France's President Emmanuel Macron said he was "very much in favour" of opening up intellectual property.

However, a French government official said it was lack of production capacity and components that was the problem rather than patents, adding: "It is the United States which has not exported a single dose to other countries and which is now talking about lifting the patents."

The UK government said in a statement that it was "working with WTO members to resolve this issue" and was in discussions with countries including the US to try to boost COVID vaccine production and supply.

Britain has previously encouraged knowledge sharing between industry and manufacturers, but stopped short of calling for IP waivers.

Those in favour of the move say it is already among the WTO's tools and there is no better time to use it than during a pandemic that has killed 3.2 million people, infected more than 400 million more, and ruined economies around the world.

Earlier Ms Tai said: "This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures.

"The administration's aim is to get as many safe and effective vaccines to as many people as fast as possible."

But those against it say producing the vaccines is difficult and the process of vaccinating the world cannot be sped up simply by easing intellectual property laws.

Frankfurt-listed shares of Pfizer, Moderna and Novavax fell 5.2%, 8.2% and 10.1% respectively on Thursday, extending losses of up to 6% seen the previous day.

London-listed shares of AstraZeneca, which has sold its vaccine not-for-profit, did not move.

Adam John Ritchie, senior project manager and vaccine scientist at the Jenner Institute, was one of the key people involved in setting up manufacture for the AstraZeneca vaccine.

He said: "It feels like trying to fight the HIV drug battle all over again.

"The manufacturing of these vaccines is much more complex, thus tech transfer becomes more important.

"Supply chains are the real bottleneck right now anyway."

Dr Richard Torbett, who heads the Association of the British Pharmaceutical Industry, told Sky's Ian King Live there were real concerns over safety in the event of a production free-for-all.

Both also said that lifting such intellectual property protections could hurt future innovation - companies can spend a lot of money researching such breakthroughs and they rely on the protections to make sure their work is not then copied by others for easy profit.

Ms Tai has also warned it will take time to reach the global consensus needed to waive the protections under WTO rules and officials have said any effect on vaccine supply will not be immediate.

Also on Wednesday, WTO director-general Ngozi Okonjo-Iweala spoke to a gathering of ambassadors from developing and developed countries about the issue.

WTO spokesman Keith Rockwell said the countries agree on the need for wider access to COVID-19 vaccines and a panel has been set up to discuss the proposal at a "tentative" meeting later this month before a formal gathering in early June.

A consensus could take some time but Mr Rockwell said there had been a recent change in tone after months of arguing, adding that the discussion was now "far more constructive, pragmatic".

"It was less emotive and less finger pointing than it had been in the past," he said.

"I think that this feeling of everyone-being-in-it-together was being expressed in a way that I had not heard to this point."

Newsletter

Related Articles

0:00
0:00
Close
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
Bessent Accuses China of Dragging Down Global Economy Amid New Trade Curbs
U.S. Revokes Visas of Foreign Nationals Who ‘Celebrated’ Charlie Kirk’s Assassination
AI and Cybersecurity at Forefront as GITEX Global 2025 Kicks Off in Dubai
DJI Loses Appeal to Remove Pentagon’s ‘Chinese Military Company’ Label
EU Deploys New Biometric Entry/Exit System: What Non-EU Travelers Must Know
Australian Prime Minister’s Private Number Exposed Through AI Contact Scraper
×